Anthrax Protective Antigen-directed Antibody Interactions [MoA] - N0000192702
Pharmacologic Class Information
| Pharmacologic Code | N0000192702 |
| Pharmacologic Name | Anthrax Protective Antigen-directed Antibody Interactions |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Mechanisms of Action - [MoA] |
| Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Anthrax Protective Antigen-directed Antibody Interactions
The table contains 2 products whose active ingredient are classified under the same pharmacologic class Anthrax Protective Antigen-directed Antibody Interactions [MoA].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 69604-204 | Anthim | Non-Proprietary Name: Obiltoxaximab | Solution | Intravenous | Elusys Therapeutics, Inc. | ACTIVE | |
| 71655-103 | Raxibacumab | Non-Proprietary Name: Raxibacumab | Injection | Intravenous | Emergent Manufacturing Operations Baltimore Llc | ACTIVE |